KalVista Pharmaceuticals
KALV
KALV
21 hedge funds and large institutions have $2.63M invested in KalVista Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$112K | |
| 2 | +$44K | |
| 3 | +$9.59K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.95K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$44 |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$398K | |
| 3 | -$183K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$54.2K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$49K |